AstraZeneca has unveiled plans to invest $15bn (£11bn) in China just months after dropping hundreds of millions of pounds of ...

AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to ...

By Andrew MacAskill and Maggie Fick BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca will invest $15 billion in ...

Keir Starmer says the move, announced during his trip to Beijing, will help support thousands of British jobs ...

This investment coincides with China’s burgeoning presence in the pharmaceutical industry, driven by an uptick in innovative ...

AstraZeneca to invest $15 billion in China through 2030 to pioneer the next-generation of innovative medicines: Cambridge, UK Friday, January 30, 2026, 09:00 Hrs [IST] AstraZeneca ...

AstraZeneca has announced a $15bn investment in China by 2030 to expand manufacturing and R&D.

The investment will be made across the value chain, from drug discovery and clinical development to production.

AstraZeneca plans to delist from Nasdaq and move to the NYSE, while its breast cancer drug Enhertu enters European regulatory review after strong trial results.

British pharmaceutical giant AstraZeneca announced on Thursday that it will invest $15 billion through 2030 in China through ...

AstraZeneca's ambitious $80 billion revenue goal by 2030 hinges on oncology growth and successful new drug launches, but faces patent expiries and fierce competition. While current financials and ...

Pharmaceutical companies AstraZeneca and Eli Lilly & Co. are planning to locate major manufacturing facilities in Albemarle and Goochland counties respectively, a state official has confirmed. Last ...